Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (111-120 of 474) with videos related to

Pageof 48
Sort By:
Journal of Endourology|April 13, 2010
Focal therapy in prostate cancer: determinants of success and failureHashim Uddin Ahmed, Caroline Moore, Emilie Lecornet, et al.
BJU International|March 18, 2014
A novel randomised controlled trial design in prostate cancerEleni Anastasiadis, Hashim Uddin Ahmed, Clare Relton, et al.
BJU International|August 24, 2006
To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?Toyoaki Uchida, Rowland O Illing, Paul J Cathcart, et al.
BJU International|August 2, 2006
The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapyToyoaki Uchida, Rowland O Illing, Paul J Cathcart, et al.
BJU International|October 10, 2006
The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysisBenedict T Blake-James, Arash Rashidian, Youko Ikeda, et al.
The Journal of Urology|June 7, 2006
Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in EnglandPaul Cathcart, Jan van der Meulen, Jim Armitage, et al.
World Journal of Urology|April 18, 2019
Role of MRI in planning radical prostatectomy: what is the added value?Jose Marenco, Clement Orczyk, Tom Collins, et al.
European Urology Oncology|January 29, 2021
Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47Naomi Morka, Benjamin S Simpson, Mark Emberton, et al.
Journal of Endourology|May 7, 2010
Conceptual basis for focal therapy in prostate cancerEmilie Lecornet, Hashim Uddin Ahmed, Caroline M Moore, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool]Jacques Irani, Christian Brown, Jan Van der Meulen, et al.
Pageof 48

Showing results (111-120 of 474) with videos related to

Sort By:
Pageof 48
Journal of Endourology|April 13, 2010
Focal therapy in prostate cancer: determinants of success and failureHashim Uddin Ahmed, Caroline Moore, Emilie Lecornet, et al.
BJU International|March 18, 2014
A novel randomised controlled trial design in prostate cancerEleni Anastasiadis, Hashim Uddin Ahmed, Clare Relton, et al.
BJU International|August 24, 2006
To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?Toyoaki Uchida, Rowland O Illing, Paul J Cathcart, et al.
BJU International|August 2, 2006
The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapyToyoaki Uchida, Rowland O Illing, Paul J Cathcart, et al.
BJU International|October 10, 2006
The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysisBenedict T Blake-James, Arash Rashidian, Youko Ikeda, et al.
The Journal of Urology|June 7, 2006
Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in EnglandPaul Cathcart, Jan van der Meulen, Jim Armitage, et al.
World Journal of Urology|April 18, 2019
Role of MRI in planning radical prostatectomy: what is the added value?Jose Marenco, Clement Orczyk, Tom Collins, et al.
European Urology Oncology|January 29, 2021
Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47Naomi Morka, Benjamin S Simpson, Mark Emberton, et al.
Journal of Endourology|May 7, 2010
Conceptual basis for focal therapy in prostate cancerEmilie Lecornet, Hashim Uddin Ahmed, Caroline M Moore, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2004
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool]Jacques Irani, Christian Brown, Jan Van der Meulen, et al.
Pageof 48